Author

M. A. Turchaninova

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:machine learning (classical)· 1 Assay:proteomics· 1

Frequent Co-Authors

D. M. Chudakov· 3 shared A. I. Mikelov· 1 shared A. R. Zaretsky· 1 shared D. B. Staroverov· 1 shared D. K. Lukyanov· 1 shared D. S. Myalik· 1 shared D. T. Marinov· 1 shared D. V. Komarov· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

D. M. Chudakov

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivApr 16, 2023

Systematic evaluation of intratumoral and peripheral BCR repertoires in three cancers

S. V. Krasik, E. A. Bryushkova, G. V. Sharonov…·E. O. Serebrovskaya

This study evaluates BCR repertoires in tumors, draining lymph nodes, and blood of cancer patients, revealing differences in clonotype expansion, hypermutation, and CDR-H3 properties.

DOI 10.7554/elife.89506

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivDec 30, 2021

Memory persistence and differentiation into antibody-secreting cells accompanied by positive selection in longitudinal BCR repertoires

A. I. Mikelov, E. I. Alekseeva, E. A. Komech…·I. V. Zvyagin

The paper analyzes longitudinal BCR repertoires to show clonal persistence and differentiation into ASCs with positive selection and affinity maturation.

DOI 10.7554/elife.79254

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintMar 4, 2021

Accounting for B cell behaviour and sampling bias yields a superior predictor of anti-PD-L1 response in bladder cancer

I. A. Dyugay, D. K. Lukyanov, M. A. Turchaninova…·D. M. Chudakov

The paper develops a RNA-Seq-based predictor of anti-PD-L1 response in bladder cancer by integrating B, NK, and T cell components and accounting for sampling bias.

DOI 10.1101/2021.03.04.433370

humanbulk RNA-seq

𝕏 PostBluesky